Brief: Kontafarma China Says Unit Enters Contract For R+D Complex At RMB33.7 Million
18/08/2025 16:04
Aug 18 (Reuters) - Kontafarma China Holdings Ltd 1312.HK: UNIT ENTERS CONTRACT FOR R+D COMPLEX AT RMB33.7 MILLION Further company coverage: 1312.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kontafarma China Holdings
See all newsBrief: Kontafarma China Holdings Announces Creditors' Voluntary Winding-Up Of Singapore Subsidiaries
Brief: Kontafarma China Appoints Li Qingshan As Executive Director And President
Brief: Kontafarma China Sees HY Consol Net Loss Of HK$67.2 Million-HK$100.7 Million
Brief: Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
Brief: Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr